查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830997

生育服务市场

Fertility Services Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

生育服务市场预计将从 2024 年的 357.9 亿美元扩大到 2031 年的 671.2 亿美元，2025-2031 年期间的复合年增长率预计为 9.3%。

市场洞察与分析师观点：生育服务市场的成长可归因于多种因素，包括医疗服务的可及性和可用性的提高；透过ICSI技术提高精子品质差的男性进行体外受精（IVF）的成功率；以及医疗保健和研究投入的增加。此外，多囊性卵巢症候群（PCOS）、子宫内膜结核和性传染病（STD）等不孕症相关疾病的发生率不断上升，也推动了市场的成长。人们对不孕症问题的认识不断提高以及医疗设施可近性的改善，也增加了已开发国家和新兴国家对这些服务的需求。近年来，不孕症相关健康问题的激增显着推动了全球市场的发展。其他促成因素包括可支配收入的增加、灵活的医疗保险覆盖范围选择以及透过电视和网路平台推广生殖服务的增加。该报告还根据生育服务市场的当前趋势（例如生育服务的推出和批准数量增加以及技术的进步）重点介绍了成长机会。

成长动力：妇科疾病发生率上升推动市场扩张输卵管阻塞等疾病通常由未治疗的性传染感染、流产併发症、产后感染和外科手术引起，可导致女性不孕。子宫内膜结核、多囊性卵巢症候群和性传染病等导致不孕的各种疾病的盛行率不断上升，这推动了生育服务市场的成长。根据 2022 年 8 月发表在《Cureus 杂誌》上的一项研究，全球女性多囊性卵巢症候群的盛行率估计在 4% 到 20% 之间。世界卫生组织 (WHO) 报告称，2021 年，全球有超过 1.16 亿女性 (3.4%) 患有多囊性卵巢症候群。此外，《柳叶刀》2020 年的一篇文章估计，中国有 2,400 万名女性患有多囊性卵巢症候群。这种情况增加了对 IVF 和各种辅助生殖技术 (ART) 的需求，从而推动了生育服务市场的成长。

策略洞察报告细分和范围：生育服务市场分析是基于程序、患者类型、最终用户和地理。市场按程序细分为辅助生殖技术、人工授精和生育手术。依患者类型分为男性和女性。就最终用户而言，市场细分为生育中心、医院和外科诊所以及其他。

細項分析：依程序划分，生育服务市场分为辅助生殖技术、人工授精及生育手术。辅助生殖技术细分市场在2023年占据最大市场份额，预计在2023年至2031年期间将呈现最高复合年增长率。此细分市场进一步细分为体外受精、卵胞浆内单一精子注射和代孕。

生育服务市场依患者类型划分，分为男性和女性两部分。 2023年，女性市场占据了更大的市场份额，而男性市场预计在预测期内将经历更高的复合年增长率。压力增加、肥胖、吸烟和饮酒等因素会导致男性不孕。此外，生育服务意识的提高、研发支出的增加、主要市场参与者推出新产品的倡议以及生活方式的改变，都在推动男性市场的成长。

就最终用户而言，生育服务市场细分为生育中心、医院及外科诊所及其他。生育中心在2023年占据了最大的市场份额，预计在预测期内将实现最高的复合年增长率。全球生育诊所数量的增长以及技术的进步正在推动该细分市场的持续增长。此外，已开发国家和新兴国家对不孕症治疗的认识不断提高，导致全球生育治疗诊所的数量增加，进一步推动了市场的成长。能够治疗不孕症的专业人员数量的不断增加、可支配收入的提高以及印度和中国等发展中国家持牌生育诊所数量的不断增加，也促进了生育中心细分市场的成长。

区域分析 - 生育服务市场：生育服务市场报告涵盖北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、义大利和欧洲其他地区）、亚太地区（韩国、中国、印度、日本、澳洲和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋和其他中东和其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和其他中美洲地区）。由于各种不孕症药物的推出和快速分销以及不孕症领域研究活动的增加，亚太地区在 2023 年占据了最大的市场份额。

2023 年，欧洲在生育服务市场份额方面排名第三。该地区的市场分为德国、英国、义大利、西班牙、法国和欧洲其他地区。众多国内市场参与者和不断上升的不孕症发病率是推动该地区市场成长的关键因素。德国是该地区市场的重要贡献者。欧洲拥有全球 40% 的 IVF 诊所，这是欧洲生育测试和治疗市场成功的关键因素。此外，该地区吸引了全球领导者的大量投资。欧洲市场的整体前景是积极的，先进的 IVF 技术吸引了私募股权公司的大量投资。此外，DIY 测试改善了不孕症测试和治疗的可及性并降低了相关成本，预计这两者都将在未来几年为市场成长创造丰厚的机会。

预计亚太地区生育服务市场将在2021年至2031年期间实现最快的复合年增长率。该地区的市场细分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。中国的成长得益于医疗旅游业的蓬勃发展和医疗基础设施的改善，预计这些因素将推动该地区生育服务的普及。此外，市场参与者在开发各种生育服务方面取得的技术进步也有望推动成长。预计未来几年，先进生育服务产品的推出和获批数量的增加将进一步促进区域市场的成长。由于不孕症率上升、晚孕趋势加剧、试管婴儿成功率提高以及可支配收入的增长，预计亚太地区市场在预测期内将经历显着增长。试管婴儿是帮助不孕症族群（包括单亲妈妈、夫妇和LGBT族群）最常用的方法之一。此外，由于生育旅游业的兴起，亚太地区的试管婴儿治疗市场具有永续发展的潜力。预计市场的成长也将受到生育诊所数量的增加和新兴地区的扩张机会的支持。

生育服务市场报告范围产业发展与未来机会 - 生育服务市场：根据生育服务市场领先公司的新闻稿，以下重点介绍了几项措施：

2022 年 10 月，Indira IVF 与 Maven Clinic 合作，后者是一家美国公司，专门透过基于远距医疗的虚拟诊所致力于女性和家庭健康。此次合作旨在让印度的 Maven 会员能够透过 Maven 平台享受 Indira IVF 的高品质临床护理和其他福利。 2022 年 8 月，Genea Fertility 担任澳洲犹太生育网络 (AJFN) 年度主要募款活动的白金赞助商。 2021 年 12 月，领先的女性健康解决方案提供商 Cooper Surgical 以 16 亿美元收购了 Generate Life Sciences，增强了其在生育和妇产科中心的服务能力。 2021 年 7 月，全球辅助生殖技术研究供应商 Hamilton Throne Ltd. 以 800 万美元收购了 IVFTECH ApS (IVFtech) 及其子公司 K4 Technology ApS，专注于用于辅助生殖技术的大容量层流工作站和孵化器。 2021 年 5 月，辅助生殖服务 (ARS) 的全球领导者 Virtus Health 宣布与澳洲生物技术和数位健康公司 Drop Bio 建立策略合作，以提高精准生育服务。 2021 年 2 月，Cooper Surgical 宣布与 Virtus Health 建立多年期策略合作关係，以推动生育治疗的创新和进步。 2020 年 11 月，Ferring BV 和 Igenomix 达成了一项为期四年的研究合作，为受怀孕相关疾病影响的患者开发新型治疗产品。竞争格局和主要公司－生育服务市场：生育服务市场的主要参与者包括 CooperSurgical, Inc.；Vitrolife；Cook Medical；Care Fertility；INVO Bioscience；Carolinas Fertility Institute；Genea Limited；Merck KgaA；LABOTECT GmbH；和 Monash IVF Group Limited。这些公司专注于开发新技术、改进现有产品并扩展地域以满足不断增长的全球需求。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：生育服务市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：生育服务市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：生育服务市场－全球市场分析

  • 生育服务 - 全球市场概览
  • 生育服务－全球市场及2031年预测

第七章：生育服务市场-收入分析-依程序，2021-2031

  • 概述
  • 辅助生殖技术
  • 人工授精
  • 生育手术

第 8 章：生育服务市场 - 收入分析 - 依病患类型，2021-2031 年

  • 概述
  • 男性
  • 女性

第九章：生育服务市场-收入分析-按最终用户，2021-2031

  • 概述
  • 生育诊所
  • 医院和外科诊所
  • 其他的

第 10 章：生育服务市场 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：生育服务市场 - 主要公司简介

  • CooperSurgical, Inc
  • Vitrolife
  • Cook Medical
  • Care Fertility
  • INVO Bioscience
  • Carolinas Fertility Institute
  • Genea Limited
  • Merck KGaA
  • LABOTECT GmbH
  • Monash IVF Group Limited

第 14 章：附录

简介目录
Product Code: TIPRE00004739

The fertility services market is anticipated to expand from US$ 35.79 billion in 2024 to US$ 67.12 billion by 2031, with a projected CAGR of 9.3% during the period of 2025-2031.

Market Insights and Analyst Perspective:The growth of the fertility services market can be attributed to several factors, including improved accessibility and availability of healthcare services; enhanced success rates of in vitro fertilization (IVF) through ICSI for men with poor sperm quality; and increased investment in healthcare and research. Additionally, the rising incidence of infertility-related medical conditions such as polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs) is propelling market growth. Growing awareness about infertility and better access to healthcare facilities have also heightened the demand for these services in both developed and emerging nations. The surge in infertility-related health issues has significantly boosted the global market in recent years. Other contributing factors include rising disposable incomes, flexible health insurance coverage options, and increased marketing of reproductive services via television and online platforms. The report also highlights growth opportunities in light of current trends in the fertility services market, such as the rise in launches and approvals for fertility services and advancements in technology.

Growth Drivers:Rising Incidence of Gynecological Disorders Fuels Market Expansion

Conditions like blocked fallopian tubes, often resulting from untreated STIs, complications from abortions, postpartum infections, and surgical procedures, can lead to infertility in women. The increasing prevalence of various diseases, including endometrial tuberculosis, PCOS, and STDs, that contribute to infertility is driving the growth of the fertility services market. According to a study published in the Cureus Journal in August 2022, the global prevalence of PCOS among women is estimated to range from 4% to 20%. The World Health Organization (WHO) reported that in 2021, PCOS affected over 116 million women (3.4%) worldwide. Furthermore, a 2020 article in The Lancet estimated that 24 million women in China suffer from PCOS. This situation is increasing the demand for IVF and various assisted reproductive technologies (ART), thereby driving the growth of the fertility services market.

Strategic Insights

Report Segmentation and Scope:The analysis of the fertility services market is conducted based on procedure, patient type, end user, and geography. The market is segmented by procedure into assisted reproductive technology, artificial insemination, and fertility surgeries. By patient type, it is divided into male and female categories. Regarding end users, the market is segmented into fertility centers, hospitals & surgical clinics, and others.

Segmental Analysis:In terms of procedure, the fertility services market is divided into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment held the largest market share in 2023 and is expected to exhibit the highest CAGR from 2023 to 2031. This segment is further divided into in vitro fertilization, intracytoplasmic sperm injection, and surrogacy.

The fertility services market, categorized by patient type, is split into male and female segments. The female segment accounted for a larger market share in 2023, while the male segment is projected to experience a higher CAGR during the forecast period. Factors such as increased stress, obesity, smoking, and alcohol consumption contribute to male infertility. Additionally, rising awareness of fertility services, increased R&D spending, initiatives by key market players to launch new products, and changing lifestyles are driving growth in the male segment.

In terms of end users, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. The growth in the number of fertility clinics globally, along with technological advancements, is propelling the market growth for this segment. Furthermore, increasing awareness of infertility treatments in both developed and emerging countries has led to a rise in the number of fertility treatment clinics worldwide, further driving market growth. The growing number of professionals capable of treating infertility, rising disposable incomes, and the increasing number of licensed fertility clinics in developing countries like India and China also contribute to the growth of the fertility centers segment.

Regional Analysis - Fertility Services Market:The fertility services market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific held the largest market share in 2023 due to the introduction and rapid distribution of various infertility medications and increased research activities in the field of infertility.

Europe ranked third in terms of market share for fertility services in 2023. The market in this region is segmented into Germany, the UK, Italy, Spain, France, and the Rest of Europe. The presence of numerous domestic market players and the rising incidence of infertility are key factors driving market growth in this region. Germany is a significant contributor to the regional market. Europe is home to 40% of all IVF clinics globally, which has been a crucial factor in the success of the European fertility testing and treatment market. Additionally, the region has attracted substantial investments from global leaders. The overall outlook for the European market is positive, with advanced IVF technology drawing significant investment from private equity firms. Moreover, do-it-yourself testing has improved access and reduced the costs associated with infertility testing and treatment, both of which are expected to create lucrative opportunities for market growth in the coming years.

The fertility services market in Asia Pacific is projected to achieve the fastest CAGR from 2021 to 2031. The market in this region is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The growth in China is driven by increasing medical tourism and enhancements in healthcare infrastructure, which are expected to boost the adoption of fertility services in the region. Additionally, technological advancements in developing various fertility services by market players are anticipated to drive growth. An increase in product launches and approvals for advanced fertility services is expected to further enhance regional market growth in the coming years. Due to rising infertility rates, a trend towards later pregnancies, improved IVF success rates, and growing disposable incomes, the market in Asia Pacific is expected to experience significant growth during the forecast period. IVF is one of the most commonly utilized methods to assist individuals affected by infertility, including single mothers, couples, and members of the LGBT community. Furthermore, the IVF treatment market in Asia Pacific has sustainable development potential due to the rise in fertility tourism. The growth of the market is also expected to be supported by the increasing number of fertility clinics and expansion opportunities in emerging regions.

Fertility Services Market Report Scope

Industry Developments and Future Opportunities - Fertility Services Market:According to press releases from leading companies in the fertility services market, several initiatives are highlighted below:

In October 2022, Indira IVF partnered with Maven Clinic, a US-based company specializing in women's and family health through telemedicine-based virtual clinics. This collaboration aims to provide Maven members in India with access to Indira IVF's high-quality clinical care and other benefits through the Maven platform.In August 2022, Genea Fertility served as a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.In December 2021, Cooper Surgical, a leading provider of women's health solutions, acquired Generate Life Sciences for US$1.6 billion, enhancing its offerings in fertility and OB/GYN centers.

In July 2021, Hamilton Throne Ltd., a global provider of ART research, acquired IVFTECH ApS (IVFtech) and its subsidiary K4 Technology ApS for US$8 million, focusing on large-capacity laminar flow workstations and incubators for ART.In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic collaboration with Drop Bio, an Australian biotechnology and digital health company, to advance precision fertility delivery.

In February 2021, Cooper Surgical announced a multi-year strategic collaboration with Virtus Health to drive innovation and advancements in fertility treatment.In November 2020, Ferring B.V. and Igenomix entered into a four-year research collaboration to develop novel therapeutic products for patients affected by pregnancy-related diseases.

Competitive Landscape and Key Companies - Fertility Services Market:Key players in the fertility services market include CooperSurgical, Inc.; Vitrolife; Cook Medical; Care Fertility; INVO Bioscience; Carolinas Fertility Institute; Genea Limited; Merck KgaA; LABOTECT GmbH; and Monash IVF Group Limited. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Fertility Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Fertility Services Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Fertility Services Market - Global Market Analysis

  • 6.1 Fertility Services - Global Market Overview
  • 6.2 Fertility Services - Global Market and Forecast to 2031

7. Fertility Services Market - Revenue Analysis (USD Million) - By Procedure, 2021-2031

  • 7.1 Overview
  • 7.2 Assisted Reproductive Technology
    • 7.2.1 In Vitro Fertilization (IVF)
    • 7.2.2 Intracytoplasmic Sperm Injection
  • 7.3 Artificial Insemination
    • 7.3.1 Intrauterine Insemination
    • 7.3.2 Intracervical Insemination
    • 7.3.3 Intratubal Insemination
  • 7.4 Fertility Surgeries

8. Fertility Services Market - Revenue Analysis (USD Million) - By Patient Type, 2021-2031

  • 8.1 Overview
  • 8.2 Male
  • 8.3 Female

9. Fertility Services Market - Revenue Analysis (USD Million) - By End-User, 2021-2031

  • 9.1 Overview
  • 9.2 Fertility Clinics
  • 9.3 Hospitals and Surgical Clinics
  • 9.4 Others

10. Fertility Services Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Fertility Services Market Overview
    • 10.1.2 North America Fertility Services Market Revenue and Forecasts to 2031
    • 10.1.3 North America Fertility Services Market Revenue and Forecasts and Analysis - By Procedure
    • 10.1.4 North America Fertility Services Market Revenue and Forecasts and Analysis - By Patient Type
    • 10.1.5 North America Fertility Services Market Revenue and Forecasts and Analysis - By End-User
    • 10.1.6 North America Fertility Services Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.7.1 United States Fertility Services Market
        • 10.1.7.1.1 United States Fertility Services Market, by Procedure
        • 10.1.7.1.2 United States Fertility Services Market, by Patient Type
        • 10.1.7.1.3 United States Fertility Services Market, by End-User
      • 10.1.7.2 Canada Fertility Services Market
        • 10.1.7.2.1 Canada Fertility Services Market, by Procedure
        • 10.1.7.2.2 Canada Fertility Services Market, by Patient Type
        • 10.1.7.2.3 Canada Fertility Services Market, by Donor Type
        • 10.1.7.2.3 Canada Fertility Services Market, by End-User
      • 10.1.7.3 Mexico Fertility Services Market
        • 10.1.7.3.1 Mexico Fertility Services Market, by Procedure
        • 10.1.7.3.2 Mexico Fertility Services Market, by Patient Type
        • 10.1.7.3.3 Mexico Fertility Services Market, by End-User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East & Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East & Africa
  • 10.5 South & Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South & Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Fertility Services Market - Key Company Profiles

  • 13.1 CooperSurgical, Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Vitrolife
  • 13.3 Cook Medical
  • 13.4 Care Fertility
  • 13.5 INVO Bioscience
  • 13.6 Carolinas Fertility Institute
  • 13.7 Genea Limited
  • 13.8 Merck KGaA
  • 13.9 LABOTECT GmbH
  • 13.10 Monash IVF Group Limited

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud